268 related articles for article (PubMed ID: 376551)
1. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.
Fierer J; Finley F
J Clin Invest; 1979 May; 63(5):912-921. PubMed ID: 376551
[TBL] [Abstract][Full Text] [Related]
2. Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis.
Akalin HE; Laleli Y; Telatar H
Q J Med; 1985 Aug; 56(220):431-7. PubMed ID: 3901076
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
4. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
Vaara M; Viljanen P; Vaara T; Mäkelä PH
J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
[TBL] [Abstract][Full Text] [Related]
5. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
Tesh VL; Duncan RL; Morrison DC
J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
[TBL] [Abstract][Full Text] [Related]
6. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
Mittal KR; Ingram DG
Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial host defense: in vitro interaction of bacteria, serum factors, and leukocytes from precolostral dairy calves and their dams.
Renshaw HW; Eckblad WP; Thacker DL; Frank FW
Am J Vet Res; 1976 Nov; 37(11):1267-74. PubMed ID: 791028
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of C9-deficient human serum.
Pramoonjago P; Kinoshita T; Hong KS; Takata-Kozono Y; Kozono H; Inagi R; Inoue K
J Immunol; 1992 Feb; 148(3):837-43. PubMed ID: 1730876
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
[TBL] [Abstract][Full Text] [Related]
11. Interaction of turkey complement with Escherichia coli isolated from turkeys.
Ellis MG; Arp LH; Lamont SJ
Am J Vet Res; 1989 Aug; 50(8):1285-9. PubMed ID: 2675694
[TBL] [Abstract][Full Text] [Related]
12. The bactericidal activity of normal human serum against Enterobacteriaceae rods with lipopolysaccharides possessing O-antigens composed of mannan.
Tichaczek-Goska D; Witkowska D; Cisowska A; Jankowski S; Hendrich AB
Adv Clin Exp Med; 2012; 21(3):289-99. PubMed ID: 23214191
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of bovine neonatal serums for selected coliform bacteria in relation to total protein and immunoglobulin G1 and immunoglobulin M concentrations.
Carroll EJ; Crenshaw GL
Am J Vet Res; 1976 Apr; 37(4):389-94. PubMed ID: 773223
[TBL] [Abstract][Full Text] [Related]
14. Factors involved in bactericidal activity of sheep serum.
Mittal KR; Ingram DG
Am J Vet Res; 1975 Aug; 36(08):1183-7. PubMed ID: 1098531
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
Traub WH
Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
[TBL] [Abstract][Full Text] [Related]
16. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
[TBL] [Abstract][Full Text] [Related]
17. [Serum resistance of Escherichia coli and serum bactericidal activity in chronic pyelonephritis].
Falkenhagen U; Handschuck I; Nimmich W; Zingler G; Naumann G
Z Urol Nephrol; 1984 Nov; 77(11):629-38. PubMed ID: 6395557
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of serum bactericidal activity against Salmonella typhimurium in sickle cell anaemia.
Hand WL; King NL
Clin Exp Immunol; 1977 Nov; 30(2):262-70. PubMed ID: 342154
[TBL] [Abstract][Full Text] [Related]
19. Human seminal plasma inhibition of complement.
Petersen BH; Lammel CJ; Stites DP; Brooks GF
J Lab Clin Med; 1980 Oct; 96(4):582-91. PubMed ID: 6775032
[TBL] [Abstract][Full Text] [Related]
20. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
